within Pharmacolibrary.Drugs.ATC.L;

model L01BB02
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.16,
    Cl             = 1.4,
    adminDuration  = 600,
    adminMass      = 0.075,
    adminCount     = 1,
    Vd             = 0.0009,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.018333333333333333,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Mercaptopurine is an antimetabolite and purine analog used primarily in the treatment of acute lymphoblastic leukemia and other hematologic malignancies. It works by inhibiting DNA and RNA synthesis in rapidly dividing cells. Mercaptopurine is still approved and commonly used as part of chemotherapy regimens.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters in adult patients with acute lymphoblastic leukemia under oral administration.</p><h4>References</h4><ol><li><p>Larsen, RH, et al., &amp; Nersting, J (2020). Pharmacokinetics of tablet and liquid formulations of oral 6-mercaptopurine in children with acute lymphoblastic leukemia. <i>Cancer chemotherapy and pharmacology</i> 86(1) 25–32. DOI:<a href=&quot;https://doi.org/10.1007/s00280-020-04097-x&quot;>10.1007/s00280-020-04097-x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/32519032/&quot;>https://pubmed.ncbi.nlm.nih.gov/32519032</a></p></li><li><p>Toksvang, LN, et al., &amp; Schmiegelow, K (2022). Maintenance therapy for acute lymphoblastic leukemia: basic science and clinical translations. <i>Leukemia</i> 36(7) 1749–1758. DOI:<a href=&quot;https://doi.org/10.1038/s41375-022-01591-4&quot;>10.1038/s41375-022-01591-4</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/35654820/&quot;>https://pubmed.ncbi.nlm.nih.gov/35654820</a></p></li><li><p>Balis, FM, et al., &amp; Bleyer, WA (1998). Pharmacokinetics and pharmacodynamics of oral methotrexate and mercaptopurine in children with lower risk acute lymphoblastic leukemia: a joint children&#x27;s cancer group and pediatric oncology branch study. <i>Blood</i> 92(10) 3569–3577. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/9808549/&quot;>https://pubmed.ncbi.nlm.nih.gov/9808549</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end L01BB02;
